Table 1 Clinical and laboratory data of the patients at the time of study
Patient Number | Age | Gender | ANCA Titre | Clinical Status | Treatment | Organ Involvement |
|---|---|---|---|---|---|---|
1 | 37 | M | PR3 60 U | Remission | Nil | R, J |
2 | 69 | M | PR3 34 U | Newly Diagnosed | Prednisolone 5 mg/day | R, J |
3 | 56 | M | PR3 >100 U | Relapse | Nil | R, J, S, P |
4 | 73 | F | PR3 >100 U | Newly Diagnosed | Nil | R, L, E |
5 | 50 | M | PR3 33 U | Newly Diagnosed | Nil | L, E, J |
6 | 63 | M | MPO >100 U | Newly Diagnosed | Nil | R, L, C, J |
7 | 77 | M | MPO 54 U | Newly Diagnosed | Nil | R, L |
8 | 67 | M | MPO 38 U | Relapse | Nil | R, L |
9 | 57 | M | MPO 47U | Relapse | Nil | R, S, L |
10 | 82 | M | MPO >100 U | Newly Diagnosed | Nil | R, J |